Farallon Capital Management’s Immunogen Inc IMGN Stock Holding History

Farallon Capital Management’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-842,000	Closed	-$25M	–	195
2023 Q4	$25M	Buy	+842,000	New	+$16.8M	0.11%	65
2021 Q3	–	Sell	-750,000	Closed	-$4.94M	–	314
2021 Q2	$4.94M	Hold	750,000	–	–	0.02%	178
2021 Q1	$6.08M	Sell	750,000 -250,000	-25%	-$2.04M	0.03%	174
2020 Q4	$6.45M	Buy	+1,000,000	New	+$5.83M	0.04%	115
2017 Q3	–	Sell	-505,000	Closed	-$3.59M	–	93
2017 Q2	$3.59M	Buy	+505,000	New	+$2.31M	0.04%	77

Other funds holding IMGN

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's IMGN Position: Q1 2024 in Review

Farallon Capital Management sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 842,000 shares — an estimated $25M sold.

Farallon Capital Management first reported a position in IMGN in Q2 2017 and held it in 5 quarters. The position peaked at $25M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

Farallon Capital Management reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
Farallon Capital Management sold 842,000 Immunogen Inc shares in Q1 2024, an estimated $25M.
Farallon Capital Management first reported a position in Immunogen Inc in Q2 2017 and held it in 5 quarters.
Farallon Capital Management's Immunogen Inc position peaked at $25M in Q4 2023.
3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Farallon Capital Management's 13F filing for Q1 2024, filed 15 May 2024.